anti-cardiolipin igg autoantibodies are an independent risk factor of covid-19 severity. This article is protected by copyright. All rights reserved.A growing body of evidence indicates that patients with cardiovascular complications are at a higher risk for developing severe Coronavirus Disease 2019 (COVID-19) (1). In addition, the high incidence of thromboembolic events suggests an important role of COVID-19-induced coagulopathy (2). Antiphospholipid autoantibodies (aPL), that are essential markers for antiphospholipid syndrome, are considered as a cardiovascular risk factor.